Systematic Financial Management LP reduced its position in Encompass Health Corp (AMEX:EHC) by 23.5% during the second quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 553,728 shares of the company’s stock after selling 170,026 shares during the period. Encompass Health accounts for about 0.9% of Systematic Financial Management LP’s portfolio, making the stock its 9th largest position. Systematic Financial Management LP owned approximately 0.56% of Encompass Health worth $37,498,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the company. BlackRock Inc. bought a new stake in shares of Encompass Health in the 1st quarter valued at about $622,184,000. JPMorgan Chase & Co. bought a new stake in shares of Encompass Health in the 1st quarter valued at about $221,881,000. Lord Abbett & CO. LLC bought a new stake in shares of Encompass Health in the 1st quarter valued at about $116,238,000. Victory Capital Management Inc. bought a new stake in shares of Encompass Health in the 1st quarter valued at about $101,978,000. Finally, Northern Trust Corp bought a new stake in shares of Encompass Health in the 1st quarter valued at about $88,764,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

EHC stock opened at $57.67 on Friday. The company has a debt-to-equity ratio of 1.89, a current ratio of 1.34 and a quick ratio of 1.34. Encompass Health Corp has a 52 week low of $40.86 and a 52 week high of $59.29.

Encompass Health (AMEX:EHC) last released its earnings results on Wednesday, July 25th. The company reported $0.99 EPS for the quarter, topping analysts’ consensus estimates of $0.83 by $0.16. The company had revenue of $1.07 billion during the quarter, compared to analysts’ expectations of $1.03 billion. Encompass Health had a net margin of 8.67% and a return on equity of 23.56%. Encompass Health’s revenue for the quarter was up 10.5% compared to the same quarter last year. equities analysts anticipate that Encompass Health Corp will post 2.72 EPS for the current year.

The business also recently announced a quarterly dividend, which will be paid on Monday, October 15th. Investors of record on Monday, October 1st will be paid a $0.27 dividend. The ex-dividend date of this dividend is Friday, September 28th. This is a boost from Encompass Health’s previous quarterly dividend of $0.25. This represents a $1.08 dividend on an annualized basis and a yield of 1.87%.

In other Encompass Health news, insider Cheryl B. Levy sold 28,955 shares of Encompass Health stock in a transaction that occurred on Friday, August 3rd. The shares were sold at an average price of $78.00, for a total transaction of $2,258,490.00. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Andrew L. Price sold 9,457 shares of Encompass Health stock in a transaction that occurred on Tuesday, August 14th. The shares were sold at an average price of $80.04, for a total transaction of $756,938.28. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

A number of analysts have recently weighed in on the stock. Mizuho restated a “buy” rating and issued a $82.00 price target on shares of Encompass Health in a report on Thursday, July 26th. Zacks Investment Research upgraded shares of Encompass Health from a “hold” rating to a “buy” rating and set a $84.00 target price for the company in a research note on Friday, July 27th. Piper Jaffray Companies upgraded shares of Encompass Health from a “neutral” rating to an “overweight” rating in a research note on Thursday, July 26th. Credit Suisse Group lifted their target price on shares of Encompass Health from $66.00 to $80.00 and gave the stock an “outperform” rating in a research note on Thursday, July 26th. Finally, SunTrust Banks reiterated a “buy” rating and issued a $82.00 target price on shares of Encompass Health in a research note on Friday, July 20th. Three equities research analysts have rated the stock with a hold rating and ten have issued a buy rating to the company. The company has a consensus rating of “Buy” and an average price target of $71.10.

Encompass Health Company Profile

Encompass Health Corporation, formerly HealthSouth Corporation, is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies.

See Also: Technical Analysis of Stocks, How Can It Help

Want to see what other hedge funds are holding EHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Encompass Health Corp (AMEX:EHC).

Institutional Ownership by Quarter for Encompass Health (AMEX:EHC)

Receive News & Ratings for Encompass Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Encompass Health and related companies with MarketBeat.com's FREE daily email newsletter.